Paranovus Entertainment Technology Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG4289N2050
USD
0.03
-0.02 (-42.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Paranovus Entertainment Technology Ltd. stock-summary
stock-summary
Paranovus Entertainment Technology Ltd.
Pharmaceuticals & Biotechnology
Happiness Biotech Group Limited. is a company mainly engaged in the research, development, manufacturing, marketing and sales of nutraceutical and dietary supplements. The Company operates four segments, including the Vitamins and Dietary Supplements Products segment, Herbal and Traditional Products segment, Sports Nutrition Products segment and Weight Management Products segment. The Company's products mainly include lucidum spore powder products, cordyceps mycelia products, ejiao solution products, vitamins and dietary supplements products, American ginseng products, and others. The Company conducts its businesses within the domestic market and to overseas markets.
Company Coordinates stock-summary
Company Details
No.11, Dongjiao East Road, Shuangxi, Shunchang NANPING FUJ : 353001
stock-summary
Tel: 86 599 7828808
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 55 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

-10.38%

stock-summary
Price to Book

2.28